Basophilia at diagnosis of myeloproliferative neoplasms was associated with a more aggressive disease phenotype and poorer ...
Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...
Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs.
Chronic lymphocytic leukemia (CLL ... rates of leukemia — particularly acute myeloid leukemia — are higher in workers exposed to high levels of benzene. Benzene is used in industries such ...
Immunomedics is also exploring additional indications, such as chronic myeloid leukemia, to broaden its therapeutic impact. Immunomedics is planning a Phase III trial targeting approximately 150 ...
Blast crisis (BC) is the final deadly phase of chronic myeloid leukemia (CML), but its molecular basis remains poorly understood. Here, we show that CML BC is regulated by calcium-calmodulin ...
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...
Howard Temin was a UW-Madison scientist who shared the 1975 Nobel Prize for his discovery of “reverse transcriptase,” which described how tumor viruses ...
The Yankees added an experienced arm to their rotation depth on Monday, as a source confirmed that the team has signed Carlos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results